VIKING GLOBAL INVESTORS LP
Institutional investor · Portfolio as of Q1 2023
Top Holdings81 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
VISA INC-CLASS A SHARES | 6.6M | $1.5B | 6.9% | $193.77 | +13.30% | 18 qtrssince 2018-Q4 | Increased 70 |
MCKESSON CORP | 3.2M | $1.1B | 5.4% | $335.65 | +5.20% | 4 qtrssince 2022-Q2 | Increased 84 |
UNITEDHEALTH GROUP INC | 2.1M | $992.4M | 4.7% | $476.38 | -6.25% | 3 qtrssince 2022-Q3 | Increased 86 |
ANTHEM INC | 2.2M | $990.7M | 4.6% | $451.14 | -2.47% | 5 qtrssince 2022-Q1 | Increased 67 |
GENERAL ELECTRIC CO COM STOCK | 8.6M | $823.3M | 3.9% | $55.33 | +33.73% | 10 qtrssince 2020-Q4 | Increased 65 |
FORTINET INC | 11.9M | $789.2M | 3.7% | $55.66 | +18.24% | 2 qtrssince 2022-Q4 | Increased 86 |
AMAZON.COM INC | 7.6M | $787.9M | 3.7% | $104.62 | -2.51% | 18 qtrssince 2018-Q4 | Decreased 0 |
API GROUP CORP | 34.1M | $766.3M | 3.6% | $8.25 | +80.21% | 12 qtrssince 2020-Q2 | Increased 58 |
LULULEMON ATHLETICA INC | 1.9M | $689.7M | 3.2% | $358.09 | 0.00% | 1 qtr | New 88 |
META PLATFORMS INC-CLASS A | 3.2M | $684.5M | 3.2% | $185.20 | +11.45% | 10 qtrssince 2020-Q4 | Increased 75 |
CHUBB LTD | 3.5M | $673.2M | 3.2% | $144.81 | +29.33% | 13 qtrssince 2020-Q1 | Decreased 0 |
CSX CORP | 22.1M | $660.4M | 3.1% | $29.27 | -3.18% | 2 qtrssince 2022-Q4 | Increased 77 |
ROIVANT SCIENCES LTD | 88.2M | $651.2M | 3.1% | $10.64 | -31.30% | 6 qtrssince 2021-Q4 | Unchanged 0 |
HDFC BANK LTD-ADR | 8.3M | $552.4M | 2.6% | $29.56 | +6.90% | 7 qtrssince 2021-Q3 | Decreased 0 |
INTUIT INC | 1.2M | $544.4M | 2.6% | $381.90 | +12.99% | 4 qtrssince 2022-Q2 | Increased 56 |
SHERWIN-WILLIAMS CO/THE | 2.3M | $506.2M | 2.4% | $211.79 | 0.00% | 1 qtr | New 81 |
THERMO FISHER SCIENTIFIC INC | 856,836 | $493.9M | 2.3% | $538.97 | +3.59% | 12 qtrssince 2020-Q2 | Increased 55 |
BRIDGEBIO PHARMA INC | 26.6M | $441.4M | 2.1% | $26.97 | -36.41% | 16 qtrssince 2019-Q2 | Unchanged 0 |
FORTIVE CORP - W/I | 6.3M | $432.6M | 2.0% | $47.49 | +5.59% | 15 qtrssince 2019-Q3 | Increased 78 |
ROYALTY PHARMA PLC- CL A | 11.2M | $403.7M | 1.9% | $37.12 | -9.35% | 12 qtrssince 2020-Q2 | Increased 55 |
VIKING GLOBAL INVESTORS LP manages $21.3B across 81 positions as of Q1 2023. Top holdings: V (6.9%), MCK (5.4%), UNH (4.7%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 2/5.0.
Active quarter - 20 new positions, 15 exits, 28 increased. Top move: LULU (NEW, conviction 88). Portfolio: $21.3B across 81 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer